SlideShare une entreprise Scribd logo
1  sur  11
Practice Quiz for Napsrx
1. How are drugs sorted into therapeutic group and classes?
A. First by the conditions that they are used to treat, and then
by their mechanisms of action
B. First by their mechanisms of action, and then by their
therapeutic effects
C. First by their side effects, and then by their therapeutic
effects
D. First by their toxicity, and then by their effectiveness
2. What section of a drug’s package insert describes situations
in which the drug should not be used because the risks outweigh
the therapeutic benefits?
A. Adverse reactions
B. Contraindications
C. Overdosage
D. Warming/precautions
3. Which of the following is NOT one of the stages in the
classic approach to band development strategy covered in your
manual?
A. Band personality
B. Band positioning
C. Band quality
D. Band values
4. What is the name of the condition that occurs after a specific
dose of a drug is given at such regular intervals that absorption
and elimination (and therefore drug plasma concentration) have
become fairly constant?
A. homeostasis
B. steady state
C. titration
D. tolerance
5. Which entity/entities invest/s the most money in
pharmaceutical R&D?
A. Canadian pharmaceutical companies
B. The NIH
C. The U.S Government
D. U.S pharmaceutical companies
6. Over the last few decades, what has happened to legal
limitations sales’ reps discussions about off label uses?
A. Limitations have decreased.
B. Limitations have increased significantly.
C. Limitations have increased slightly.
D. Limitations have remained about the same.
7. Why are novice sales representatives often placed in
charge of negotiating MCO formularies?
A. to become more familiar with the healthcare industry
B. to be more familiar with their territories
C. P&T committees are more receptive to new experienced reps.
D. They are not. This job is usually reserved for more
experienced reps.
8. Which of the following is an example of a central value?
A. I buy Advil to show that I’m modern consumer.
B. I like Advil because we were both born in the 80s.
C. I prefer Advil because I like the flavor.
D. I prefer Advil because it’s easier to swallow.
9. Which of the following specialties likely has the MOST
emergency calls?
A. Cardiology
B. Psychiatry
C. Urology
D. All specialists have the same number of emergency calls
10. What affects the rate of active transport?
A. The availability of carriers, but not energy
B. The availability of energy, but not carriers
C. The availability of carriers and energy
D. Neither the availability of carriers nor the availability of
energy
11. Over the last few decades, what has happened to the FDA
approval time for new drugs?
A. It has been lengthened to ensure safer drug products.
B. It has been lengthened to limit DTC marketing.
C. It has been shortened to improve drug quality.
D. It has been shortened to reduce the cost of new drug
development.
12. Which of the following would NOT help improve
compliance?
A. Patients liking their providers
B. Patients using only one pharmacist
C. Pharmacists understanding how generics differ from brand
name drugs
D. Support groups
13. As the price a patient pays for prescription increases, what
happens to the likelihood that the patient will fill it?
A. It decreases
B. It increases
C. It remains unaffected because the prescription is needed
D. It remains unaffected because the prescription’s increased
cost is offset by its perceived value
14. Which of the following is NOT one of the body’s major
organ systems?
A. The cardiovascular system
B. The cellular system
C. The gastrointestinal system
D. The musculoskeletal system
15. How do most drugs exert their primary physiological
effects?
A. By activating synapses between different types of tissues
B. By binding to cell receptors that are sensitive to their
presence
C. By inhibiting synapses between different types of tissues
D. Through genetic mutation
16. What should a sale representative do if all of the prime
spaces in a drug cabinet are occupied?
A. Ask staff for permission to move some of the other products
in the cabinet
B. Ask staff for permission to throw away expired product in
the cabinet
C. Ask the doctor if he still needs some of the other products in
the cabinet
D. Surreptitiously move your largest competitor’s products out
of the way
17. It is inappropriate for physicians’ prescribing behaviors to
be educated by their personal tastes and idiosyncrasies
A. True
B. False
18. The FDA defines API as the active----------ingredient in a
drug, which produces the desired change in the body.
A. Pharmaceutical
B. Positive
C. Potent
D. Primary
19. What term describes the usage of a medication for purposes
other than the FDA-approved indications on the labeling?
A. Contraindicative indication
B. Off-indication usage
C. Off label use
D. Off usage
20. What is typically NOT a characteristic of a pharmaceutical
rep?
A. Pharmaceutical sales reps are authentic and real.
B. Pharmaceutical sales reps are creative.
C. Pharmaceutical sale reps are focused.
D. Pharmaceutical sale reps are not concerned about
competitors.
21. Which of the following refers to all active and inert
pharmaceutical ingredients in a drug, including fillers and
colors?
A. Formulation
B. Mycoplasma
C. Peptide
D. Saccharide
22. Senior citizens consume over--------times as many
pharmaceutical as people under 65.
A. Three
B. Five
C. Ten
D. Fifteen
23. What is passive diffusion?
A. A type of pinocytosis
B. Membrane transport via vesicles
C. The use of energy to help a substance pass from a low
concentration gradient to a high one
D. When a substance freely moves through a membrane from a
high concentration gradient to a low one
24. What are all metabolites?
A. Type of pinocytosis
B. Membrane transport via vesicles]
C. The use of energy to help a substance pass a low
concentration gradient to a high one
D. When a substance freely moves through a membrane from a
high concentration gradient to a low one
25. When a drug is administered orally, where does first-pass
metabolism occur?
A. Intestine
B. Liver
C. Pancreas
D. Stomach
26. Which of the following is NOT part of the Seven Step
Cascade of Emotion?
A. Be a consultant, not a rep
B. Identify what your product does
C. Reflect
D. Visualize the power 10
27. If a sales representative’s product is placed on the second
tier of a standard three-tier formulary, which of the following is
most likely true?
A. It has not been reviewed by the P&T committee.
B. It is in a neutral position unless it is at parity with other
drugs
C. It probably has exclusive preferred status if it is not at parity
with any other drugs.
D. It will essentially sell itself if it is granted exclusive
preferred status.
28. According to your manual, what is a common complaint that
physicians have about traditional sampling methods?
A. That drug sample supply is too unpredictable
B. That patients are less likely to take free samples because
they think they are lower quality
C. That patients do not like seeing drug representatives in their
offices
D. That they receive too many drug samples
29. Which of the following would help you build trust with a
physician?
A. Asking if he or she is having any problems with the managed
care coverage of your products
B. Repeating a question you already asked
C. Surprising the office staff with a new poster in the break
room
D. None of these would help you build trust with a physician
30. As of November 2013, which of these countries has
legalized DTC advertising of prescription drugs?
A. Canada
B. Japan
C. Spain
D. None of these
31. Which phase of clinical trial is also known as the pivotal
phase?
A. Phase I
B. Phase III
C. Phase IV
D. Phase IX
32. During which phase of clinical trials is also known as the
pivotal phase?
A. Preclinical
B. Phase I
C. Phase II
D. Phase III
33. What is one of the biggest time wasters for a pharmaceutical
sales rep?
A. Winterers
B. Pharmacists
C. Receptionists
D. Physicians
34. What is the percentage fee that the dispenser pays the
wholesaler for distribution?
A. Margin fee
B. Recharge
C. Standard fee
D. Upcharge
35. Which of the following is an example of noncompliance?
A. A patient forgetting to take a drug at a specified time of day
B. A patient taking a drug, but only because it has been court-
mandated
C. A pharmacist dispensing a generic equivalent of a drug
instead of the brand name
D. A physician refusing to prescribe a drug because he or she
does not trust the clinical studies on it
36. What is one way in which pharmaceutical selling is different
from selling in most other industries?
A. In pharmaceutical sales, the decision-makers consumers, and
payers are usually the same entity
B. Pharmaceutical selling takes less time because doctors are so
busy.
C. Representatives do NOT sell to the user of the product.
D. Representatives DO sell to the end user of the product
37. Drugs can be used----- days beyond their expiration date.
A. 2-7 days, depending on the most current monograph.
B. 2-90 days, depending on the state laws
C. 7-90 days, depending on the type of drug and its therapeutic
class.
D. None of these
38. What issue has MOST encouraged consumers’ desire to see
more OTC medications?
A. A weaker patients ‘right movement
B. Lack of insurance coverage
C. Less reliance on the internet
D. Proliferation of herbal remedies
39. Which phase of trials largely determines the clinical dose?
A. Preclinical trials
B. Phase II trials
C. Phase III trials
D. Phase IV trials
40. What must be contained in the Description section of a
pharmaceutical package insert?
A. Adverse effects
B. Mechanism of action
C. Pharmacokinetics
D. The proprietary name and the established name
41. Customers purchase products from people they like, trust,
and respect. This is called the----------
A. Closing of the sale
B. First time advantage
C. Likeability factor
D. Power of knowledge
42. According to your manual, how has the U.S. healthcare
marketplace changed in the last few decades?
A. Fewer and fewer prescription drugs have been made
available as OTCs.
B. Managed care has been increasingly replaced by more
patient- centered approaches.
C. The aging Baby Boomer generation has begun demanding
more personalized attention.
D. There has been decreased emphasis on preventive health.
43. How does pharmaceutical marketing help narrow the
treatment gap?
A. It encourages patients to take more active roles in their
healthcare.
B. It makes doctors more skeptical of the pharmaceutical
industry.
C. It makes patients more skeptical of their doctors’ opinions.
D. All of these
44. The FDA requirements for nutraceuticals and medicinal
herbs are just as stringent as for pharmaceuticals.
A. True
B. False
45. After a trade-name drug’s patent expires, how may generic
versions of it be sold?
A. Only under the branded generic name
B. Only under the generic name
C. Only under the original trade name
D. Under the original trade name or a generic name
46. What is required for a new pharmaceutical to be considered
a viable therapy?
A. It causes no serious adverse effects.
B. It causes no side effects.
C. It has an active placebo.
D. It is more effective and/or causes fewer serious adverse
effects than other drugs on the market.
47. A generic version is likely to have some inactive
ingredients that are different from those of the original drug.
A. True
B. False
48. Where are most drugs metabolized?
A. Interstitial spaces
B. Liver
C. Stomach
D. The bloodstream
49. What is essential to the ethical requirement that subjects be
selected fairly?
A. Selection criteria should be well-supported by documented
evidence.
B. Studies should make every attempt to conduct research on
subjects who are underprivileged and in need of medical
attention
C. Subject should be selected based on scientific objectives.
D. All of these
50. Which of the following is NOT typically included in the
indications and usage section of the package insert information?
A. Diseases or conditions that the drug is approved to treat
B. The drug’s active metabolites
C. The drug’s recommended usual dosage
D. The drug’s usual dosage range

Contenu connexe

Similaire à Practice Quiz for Napsrx1. How are drugs sorted into therapeutic.docx

Answers.docx
Answers.docxAnswers.docx
Answers.docxwrite12
 
A Survey report on otc products and its market status
A Survey report on otc products and its market statusA Survey report on otc products and its market status
A Survey report on otc products and its market statusDeep Shah
 
Hospital Formulary system
Hospital Formulary systemHospital Formulary system
Hospital Formulary systemanand kakde
 
Over the Counter Drugs (OTC DRUGS)
Over the Counter Drugs (OTC DRUGS)Over the Counter Drugs (OTC DRUGS)
Over the Counter Drugs (OTC DRUGS)Umair hanif
 
Publisher Prentice Hall PSY560 Clinical Psychology Te.docx
Publisher Prentice Hall PSY560 Clinical Psychology Te.docxPublisher Prentice Hall PSY560 Clinical Psychology Te.docx
Publisher Prentice Hall PSY560 Clinical Psychology Te.docxamrit47
 
AETCOM all competencies.pptx pathology practical
AETCOM  all competencies.pptx pathology practicalAETCOM  all competencies.pptx pathology practical
AETCOM all competencies.pptx pathology practical59w4pymhcm
 
Medication safety - Second Lecture
Medication safety - Second LectureMedication safety - Second Lecture
Medication safety - Second LectureKurt Wilson
 
The Role of clinical Research in Pharmaceuticals Industry
The Role of clinical Research in Pharmaceuticals IndustryThe Role of clinical Research in Pharmaceuticals Industry
The Role of clinical Research in Pharmaceuticals IndustryVarsha Chauhan
 
clinical pharmacy and modern dispensing practice. ...docx
clinical pharmacy and modern dispensing practice. ...docxclinical pharmacy and modern dispensing practice. ...docx
clinical pharmacy and modern dispensing practice. ...docxPriyayannawar4
 
CPPS-qs_Collection...QUESTION OF CPPS EXAM
CPPS-qs_Collection...QUESTION OF CPPS  EXAMCPPS-qs_Collection...QUESTION OF CPPS  EXAM
CPPS-qs_Collection...QUESTION OF CPPS EXAMssuser7e82f41
 
Challenges for drug development jsr slides aug 2013
Challenges for drug development jsr slides aug 2013Challenges for drug development jsr slides aug 2013
Challenges for drug development jsr slides aug 2013CincyTechUSA
 
Health literacy toolkit tool #9 pharmacist consultation tool9
Health literacy toolkit tool #9 pharmacist consultation   tool9Health literacy toolkit tool #9 pharmacist consultation   tool9
Health literacy toolkit tool #9 pharmacist consultation tool9marta halim
 
MRIM-Assignment - 2final.pdf
MRIM-Assignment - 2final.pdfMRIM-Assignment - 2final.pdf
MRIM-Assignment - 2final.pdfSamrinKhan18
 
Clinical trials I II III
Clinical trials I II IIIClinical trials I II III
Clinical trials I II IIInandhujaan
 
Physician Dispensing Key in Reducing Billions to US Healthcare Costs
Physician Dispensing Key in Reducing Billions to US Healthcare CostsPhysician Dispensing Key in Reducing Billions to US Healthcare Costs
Physician Dispensing Key in Reducing Billions to US Healthcare CostsBRP Pharmaceuticals
 

Similaire à Practice Quiz for Napsrx1. How are drugs sorted into therapeutic.docx (20)

Answers.docx
Answers.docxAnswers.docx
Answers.docx
 
Chn2
Chn2Chn2
Chn2
 
A Survey report on otc products and its market status
A Survey report on otc products and its market statusA Survey report on otc products and its market status
A Survey report on otc products and its market status
 
Hospital Formulary system
Hospital Formulary systemHospital Formulary system
Hospital Formulary system
 
Over the Counter Drugs (OTC DRUGS)
Over the Counter Drugs (OTC DRUGS)Over the Counter Drugs (OTC DRUGS)
Over the Counter Drugs (OTC DRUGS)
 
Publisher Prentice Hall PSY560 Clinical Psychology Te.docx
Publisher Prentice Hall PSY560 Clinical Psychology Te.docxPublisher Prentice Hall PSY560 Clinical Psychology Te.docx
Publisher Prentice Hall PSY560 Clinical Psychology Te.docx
 
AETCOM all competencies.pptx pathology practical
AETCOM  all competencies.pptx pathology practicalAETCOM  all competencies.pptx pathology practical
AETCOM all competencies.pptx pathology practical
 
Medication safety - Second Lecture
Medication safety - Second LectureMedication safety - Second Lecture
Medication safety - Second Lecture
 
The Role of clinical Research in Pharmaceuticals Industry
The Role of clinical Research in Pharmaceuticals IndustryThe Role of clinical Research in Pharmaceuticals Industry
The Role of clinical Research in Pharmaceuticals Industry
 
clinical pharmacy and modern dispensing practice. ...docx
clinical pharmacy and modern dispensing practice. ...docxclinical pharmacy and modern dispensing practice. ...docx
clinical pharmacy and modern dispensing practice. ...docx
 
The importance of clinician engagement in the HTA process
The importance of clinician engagement in the HTA processThe importance of clinician engagement in the HTA process
The importance of clinician engagement in the HTA process
 
Chapter 3
Chapter 3Chapter 3
Chapter 3
 
CPPS-qs_Collection...QUESTION OF CPPS EXAM
CPPS-qs_Collection...QUESTION OF CPPS  EXAMCPPS-qs_Collection...QUESTION OF CPPS  EXAM
CPPS-qs_Collection...QUESTION OF CPPS EXAM
 
Challenges for drug development jsr slides aug 2013
Challenges for drug development jsr slides aug 2013Challenges for drug development jsr slides aug 2013
Challenges for drug development jsr slides aug 2013
 
Health literacy toolkit tool #9 pharmacist consultation tool9
Health literacy toolkit tool #9 pharmacist consultation   tool9Health literacy toolkit tool #9 pharmacist consultation   tool9
Health literacy toolkit tool #9 pharmacist consultation tool9
 
MRIM-Assignment - 2final.pdf
MRIM-Assignment - 2final.pdfMRIM-Assignment - 2final.pdf
MRIM-Assignment - 2final.pdf
 
A. SANDHYA RANI
A. SANDHYA RANIA. SANDHYA RANI
A. SANDHYA RANI
 
Clinical trials I II III
Clinical trials I II IIIClinical trials I II III
Clinical trials I II III
 
BRP Pharmaceuticals
BRP PharmaceuticalsBRP Pharmaceuticals
BRP Pharmaceuticals
 
Physician Dispensing Key in Reducing Billions to US Healthcare Costs
Physician Dispensing Key in Reducing Billions to US Healthcare CostsPhysician Dispensing Key in Reducing Billions to US Healthcare Costs
Physician Dispensing Key in Reducing Billions to US Healthcare Costs
 

Plus de ChantellPantoja184

Problem 20-1A Production cost flow and measurement; journal entrie.docx
Problem 20-1A Production cost flow and measurement; journal entrie.docxProblem 20-1A Production cost flow and measurement; journal entrie.docx
Problem 20-1A Production cost flow and measurement; journal entrie.docxChantellPantoja184
 
Problem 2 Obtain Io.Let x be the current through j2, ..docx
Problem 2 Obtain Io.Let x be the current through j2, ..docxProblem 2 Obtain Io.Let x be the current through j2, ..docx
Problem 2 Obtain Io.Let x be the current through j2, ..docxChantellPantoja184
 
Problem 1On April 1, 20X4, Rojas purchased land by giving $100,000.docx
Problem 1On April 1, 20X4, Rojas purchased land by giving $100,000.docxProblem 1On April 1, 20X4, Rojas purchased land by giving $100,000.docx
Problem 1On April 1, 20X4, Rojas purchased land by giving $100,000.docxChantellPantoja184
 
Problem 17-1 Dividends and Taxes [LO2]Dark Day, Inc., has declar.docx
Problem 17-1 Dividends and Taxes [LO2]Dark Day, Inc., has declar.docxProblem 17-1 Dividends and Taxes [LO2]Dark Day, Inc., has declar.docx
Problem 17-1 Dividends and Taxes [LO2]Dark Day, Inc., has declar.docxChantellPantoja184
 
Problem 1Problem 1 - Constant-Growth Common StockWhat is the value.docx
Problem 1Problem 1 - Constant-Growth Common StockWhat is the value.docxProblem 1Problem 1 - Constant-Growth Common StockWhat is the value.docx
Problem 1Problem 1 - Constant-Growth Common StockWhat is the value.docxChantellPantoja184
 
Problem 1Prescott, Inc., manufactures bookcases and uses an activi.docx
Problem 1Prescott, Inc., manufactures bookcases and uses an activi.docxProblem 1Prescott, Inc., manufactures bookcases and uses an activi.docx
Problem 1Prescott, Inc., manufactures bookcases and uses an activi.docxChantellPantoja184
 
Problem 1Preston Recliners manufactures leather recliners and uses.docx
Problem 1Preston Recliners manufactures leather recliners and uses.docxProblem 1Preston Recliners manufactures leather recliners and uses.docx
Problem 1Preston Recliners manufactures leather recliners and uses.docxChantellPantoja184
 
Problem 1Pro Forma Income Statement and Balance SheetBelow is the .docx
Problem 1Pro Forma Income Statement and Balance SheetBelow is the .docxProblem 1Pro Forma Income Statement and Balance SheetBelow is the .docx
Problem 1Pro Forma Income Statement and Balance SheetBelow is the .docxChantellPantoja184
 
Problem 2-1PROBLEM 2-1Solution Legend= Value given in problemGiven.docx
Problem 2-1PROBLEM 2-1Solution Legend= Value given in problemGiven.docxProblem 2-1PROBLEM 2-1Solution Legend= Value given in problemGiven.docx
Problem 2-1PROBLEM 2-1Solution Legend= Value given in problemGiven.docxChantellPantoja184
 
PROBLEM 14-6AProblem 14-6A Norwoods Borrowings1. Total amount of .docx
PROBLEM 14-6AProblem 14-6A Norwoods Borrowings1. Total amount of .docxPROBLEM 14-6AProblem 14-6A Norwoods Borrowings1. Total amount of .docx
PROBLEM 14-6AProblem 14-6A Norwoods Borrowings1. Total amount of .docxChantellPantoja184
 
Problem 13-3AThe stockholders’ equity accounts of Ashley Corpo.docx
Problem 13-3AThe stockholders’ equity accounts of Ashley Corpo.docxProblem 13-3AThe stockholders’ equity accounts of Ashley Corpo.docx
Problem 13-3AThe stockholders’ equity accounts of Ashley Corpo.docxChantellPantoja184
 
Problem 12-9AYour answer is partially correct.  Try again..docx
Problem 12-9AYour answer is partially correct.  Try again..docxProblem 12-9AYour answer is partially correct.  Try again..docx
Problem 12-9AYour answer is partially correct.  Try again..docxChantellPantoja184
 
Problem 1123456Xf122437455763715813910106Name DateTopic.docx
Problem 1123456Xf122437455763715813910106Name DateTopic.docxProblem 1123456Xf122437455763715813910106Name DateTopic.docx
Problem 1123456Xf122437455763715813910106Name DateTopic.docxChantellPantoja184
 
Problem 1. For the truss and loading shown below, calculate th.docx
Problem 1. For the truss and loading shown below, calculate th.docxProblem 1. For the truss and loading shown below, calculate th.docx
Problem 1. For the truss and loading shown below, calculate th.docxChantellPantoja184
 
Problem 1 (30 marks)Review enough information about .docx
Problem 1 (30 marks)Review enough information about .docxProblem 1 (30 marks)Review enough information about .docx
Problem 1 (30 marks)Review enough information about .docxChantellPantoja184
 
Problem 1 (10 points) Note that an eigenvector cannot be zero.docx
Problem 1 (10 points) Note that an eigenvector cannot be zero.docxProblem 1 (10 points) Note that an eigenvector cannot be zero.docx
Problem 1 (10 points) Note that an eigenvector cannot be zero.docxChantellPantoja184
 
Probation and Parole 3Running head Probation and Parole.docx
Probation and Parole 3Running head Probation and Parole.docxProbation and Parole 3Running head Probation and Parole.docx
Probation and Parole 3Running head Probation and Parole.docxChantellPantoja184
 
Problem 1(a) Complete the following ANOVA table based on 20 obs.docx
Problem 1(a) Complete the following ANOVA table based on 20 obs.docxProblem 1(a) Complete the following ANOVA table based on 20 obs.docx
Problem 1(a) Complete the following ANOVA table based on 20 obs.docxChantellPantoja184
 
Probe 140 SPrecipitation in inchesTemperature in F.docx
Probe 140 SPrecipitation in inchesTemperature in F.docxProbe 140 SPrecipitation in inchesTemperature in F.docx
Probe 140 SPrecipitation in inchesTemperature in F.docxChantellPantoja184
 

Plus de ChantellPantoja184 (20)

Problem 1Problem 2.docx
Problem 1Problem 2.docxProblem 1Problem 2.docx
Problem 1Problem 2.docx
 
Problem 20-1A Production cost flow and measurement; journal entrie.docx
Problem 20-1A Production cost flow and measurement; journal entrie.docxProblem 20-1A Production cost flow and measurement; journal entrie.docx
Problem 20-1A Production cost flow and measurement; journal entrie.docx
 
Problem 2 Obtain Io.Let x be the current through j2, ..docx
Problem 2 Obtain Io.Let x be the current through j2, ..docxProblem 2 Obtain Io.Let x be the current through j2, ..docx
Problem 2 Obtain Io.Let x be the current through j2, ..docx
 
Problem 1On April 1, 20X4, Rojas purchased land by giving $100,000.docx
Problem 1On April 1, 20X4, Rojas purchased land by giving $100,000.docxProblem 1On April 1, 20X4, Rojas purchased land by giving $100,000.docx
Problem 1On April 1, 20X4, Rojas purchased land by giving $100,000.docx
 
Problem 17-1 Dividends and Taxes [LO2]Dark Day, Inc., has declar.docx
Problem 17-1 Dividends and Taxes [LO2]Dark Day, Inc., has declar.docxProblem 17-1 Dividends and Taxes [LO2]Dark Day, Inc., has declar.docx
Problem 17-1 Dividends and Taxes [LO2]Dark Day, Inc., has declar.docx
 
Problem 1Problem 1 - Constant-Growth Common StockWhat is the value.docx
Problem 1Problem 1 - Constant-Growth Common StockWhat is the value.docxProblem 1Problem 1 - Constant-Growth Common StockWhat is the value.docx
Problem 1Problem 1 - Constant-Growth Common StockWhat is the value.docx
 
Problem 1Prescott, Inc., manufactures bookcases and uses an activi.docx
Problem 1Prescott, Inc., manufactures bookcases and uses an activi.docxProblem 1Prescott, Inc., manufactures bookcases and uses an activi.docx
Problem 1Prescott, Inc., manufactures bookcases and uses an activi.docx
 
Problem 1Preston Recliners manufactures leather recliners and uses.docx
Problem 1Preston Recliners manufactures leather recliners and uses.docxProblem 1Preston Recliners manufactures leather recliners and uses.docx
Problem 1Preston Recliners manufactures leather recliners and uses.docx
 
Problem 1Pro Forma Income Statement and Balance SheetBelow is the .docx
Problem 1Pro Forma Income Statement and Balance SheetBelow is the .docxProblem 1Pro Forma Income Statement and Balance SheetBelow is the .docx
Problem 1Pro Forma Income Statement and Balance SheetBelow is the .docx
 
Problem 2-1PROBLEM 2-1Solution Legend= Value given in problemGiven.docx
Problem 2-1PROBLEM 2-1Solution Legend= Value given in problemGiven.docxProblem 2-1PROBLEM 2-1Solution Legend= Value given in problemGiven.docx
Problem 2-1PROBLEM 2-1Solution Legend= Value given in problemGiven.docx
 
PROBLEM 14-6AProblem 14-6A Norwoods Borrowings1. Total amount of .docx
PROBLEM 14-6AProblem 14-6A Norwoods Borrowings1. Total amount of .docxPROBLEM 14-6AProblem 14-6A Norwoods Borrowings1. Total amount of .docx
PROBLEM 14-6AProblem 14-6A Norwoods Borrowings1. Total amount of .docx
 
Problem 13-3AThe stockholders’ equity accounts of Ashley Corpo.docx
Problem 13-3AThe stockholders’ equity accounts of Ashley Corpo.docxProblem 13-3AThe stockholders’ equity accounts of Ashley Corpo.docx
Problem 13-3AThe stockholders’ equity accounts of Ashley Corpo.docx
 
Problem 12-9AYour answer is partially correct.  Try again..docx
Problem 12-9AYour answer is partially correct.  Try again..docxProblem 12-9AYour answer is partially correct.  Try again..docx
Problem 12-9AYour answer is partially correct.  Try again..docx
 
Problem 1123456Xf122437455763715813910106Name DateTopic.docx
Problem 1123456Xf122437455763715813910106Name DateTopic.docxProblem 1123456Xf122437455763715813910106Name DateTopic.docx
Problem 1123456Xf122437455763715813910106Name DateTopic.docx
 
Problem 1. For the truss and loading shown below, calculate th.docx
Problem 1. For the truss and loading shown below, calculate th.docxProblem 1. For the truss and loading shown below, calculate th.docx
Problem 1. For the truss and loading shown below, calculate th.docx
 
Problem 1 (30 marks)Review enough information about .docx
Problem 1 (30 marks)Review enough information about .docxProblem 1 (30 marks)Review enough information about .docx
Problem 1 (30 marks)Review enough information about .docx
 
Problem 1 (10 points) Note that an eigenvector cannot be zero.docx
Problem 1 (10 points) Note that an eigenvector cannot be zero.docxProblem 1 (10 points) Note that an eigenvector cannot be zero.docx
Problem 1 (10 points) Note that an eigenvector cannot be zero.docx
 
Probation and Parole 3Running head Probation and Parole.docx
Probation and Parole 3Running head Probation and Parole.docxProbation and Parole 3Running head Probation and Parole.docx
Probation and Parole 3Running head Probation and Parole.docx
 
Problem 1(a) Complete the following ANOVA table based on 20 obs.docx
Problem 1(a) Complete the following ANOVA table based on 20 obs.docxProblem 1(a) Complete the following ANOVA table based on 20 obs.docx
Problem 1(a) Complete the following ANOVA table based on 20 obs.docx
 
Probe 140 SPrecipitation in inchesTemperature in F.docx
Probe 140 SPrecipitation in inchesTemperature in F.docxProbe 140 SPrecipitation in inchesTemperature in F.docx
Probe 140 SPrecipitation in inchesTemperature in F.docx
 

Dernier

Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxJisc
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentationcamerronhm
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - Englishneillewis46
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...Nguyen Thanh Tu Collection
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17Celine George
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfNirmal Dwivedi
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.MaryamAhmad92
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptxMaritesTamaniVerdade
 
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...Amil baba
 
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxannathomasp01
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Pooja Bhuva
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Pooja Bhuva
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxAreebaZafar22
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxRamakrishna Reddy Bijjam
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxDenish Jangid
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxmarlenawright1
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17Celine George
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the ClassroomPooky Knightsmith
 

Dernier (20)

Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
 
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 

Practice Quiz for Napsrx1. How are drugs sorted into therapeutic.docx

  • 1. Practice Quiz for Napsrx 1. How are drugs sorted into therapeutic group and classes? A. First by the conditions that they are used to treat, and then by their mechanisms of action B. First by their mechanisms of action, and then by their therapeutic effects C. First by their side effects, and then by their therapeutic effects D. First by their toxicity, and then by their effectiveness 2. What section of a drug’s package insert describes situations in which the drug should not be used because the risks outweigh the therapeutic benefits? A. Adverse reactions B. Contraindications C. Overdosage D. Warming/precautions 3. Which of the following is NOT one of the stages in the classic approach to band development strategy covered in your manual? A. Band personality B. Band positioning C. Band quality D. Band values 4. What is the name of the condition that occurs after a specific dose of a drug is given at such regular intervals that absorption and elimination (and therefore drug plasma concentration) have become fairly constant? A. homeostasis B. steady state C. titration D. tolerance
  • 2. 5. Which entity/entities invest/s the most money in pharmaceutical R&D? A. Canadian pharmaceutical companies B. The NIH C. The U.S Government D. U.S pharmaceutical companies 6. Over the last few decades, what has happened to legal limitations sales’ reps discussions about off label uses? A. Limitations have decreased. B. Limitations have increased significantly. C. Limitations have increased slightly. D. Limitations have remained about the same. 7. Why are novice sales representatives often placed in charge of negotiating MCO formularies? A. to become more familiar with the healthcare industry B. to be more familiar with their territories C. P&T committees are more receptive to new experienced reps. D. They are not. This job is usually reserved for more experienced reps. 8. Which of the following is an example of a central value? A. I buy Advil to show that I’m modern consumer. B. I like Advil because we were both born in the 80s. C. I prefer Advil because I like the flavor. D. I prefer Advil because it’s easier to swallow. 9. Which of the following specialties likely has the MOST emergency calls? A. Cardiology B. Psychiatry C. Urology D. All specialists have the same number of emergency calls 10. What affects the rate of active transport? A. The availability of carriers, but not energy
  • 3. B. The availability of energy, but not carriers C. The availability of carriers and energy D. Neither the availability of carriers nor the availability of energy 11. Over the last few decades, what has happened to the FDA approval time for new drugs? A. It has been lengthened to ensure safer drug products. B. It has been lengthened to limit DTC marketing. C. It has been shortened to improve drug quality. D. It has been shortened to reduce the cost of new drug development. 12. Which of the following would NOT help improve compliance? A. Patients liking their providers B. Patients using only one pharmacist C. Pharmacists understanding how generics differ from brand name drugs D. Support groups 13. As the price a patient pays for prescription increases, what happens to the likelihood that the patient will fill it? A. It decreases B. It increases C. It remains unaffected because the prescription is needed D. It remains unaffected because the prescription’s increased cost is offset by its perceived value 14. Which of the following is NOT one of the body’s major organ systems? A. The cardiovascular system B. The cellular system C. The gastrointestinal system D. The musculoskeletal system
  • 4. 15. How do most drugs exert their primary physiological effects? A. By activating synapses between different types of tissues B. By binding to cell receptors that are sensitive to their presence C. By inhibiting synapses between different types of tissues D. Through genetic mutation 16. What should a sale representative do if all of the prime spaces in a drug cabinet are occupied? A. Ask staff for permission to move some of the other products in the cabinet B. Ask staff for permission to throw away expired product in the cabinet C. Ask the doctor if he still needs some of the other products in the cabinet D. Surreptitiously move your largest competitor’s products out of the way 17. It is inappropriate for physicians’ prescribing behaviors to be educated by their personal tastes and idiosyncrasies A. True B. False 18. The FDA defines API as the active----------ingredient in a drug, which produces the desired change in the body. A. Pharmaceutical B. Positive C. Potent D. Primary 19. What term describes the usage of a medication for purposes other than the FDA-approved indications on the labeling? A. Contraindicative indication B. Off-indication usage C. Off label use D. Off usage
  • 5. 20. What is typically NOT a characteristic of a pharmaceutical rep? A. Pharmaceutical sales reps are authentic and real. B. Pharmaceutical sales reps are creative. C. Pharmaceutical sale reps are focused. D. Pharmaceutical sale reps are not concerned about competitors. 21. Which of the following refers to all active and inert pharmaceutical ingredients in a drug, including fillers and colors? A. Formulation B. Mycoplasma C. Peptide D. Saccharide 22. Senior citizens consume over--------times as many pharmaceutical as people under 65. A. Three B. Five C. Ten D. Fifteen 23. What is passive diffusion? A. A type of pinocytosis B. Membrane transport via vesicles C. The use of energy to help a substance pass from a low concentration gradient to a high one D. When a substance freely moves through a membrane from a high concentration gradient to a low one 24. What are all metabolites? A. Type of pinocytosis B. Membrane transport via vesicles] C. The use of energy to help a substance pass a low concentration gradient to a high one
  • 6. D. When a substance freely moves through a membrane from a high concentration gradient to a low one 25. When a drug is administered orally, where does first-pass metabolism occur? A. Intestine B. Liver C. Pancreas D. Stomach 26. Which of the following is NOT part of the Seven Step Cascade of Emotion? A. Be a consultant, not a rep B. Identify what your product does C. Reflect D. Visualize the power 10 27. If a sales representative’s product is placed on the second tier of a standard three-tier formulary, which of the following is most likely true? A. It has not been reviewed by the P&T committee. B. It is in a neutral position unless it is at parity with other drugs C. It probably has exclusive preferred status if it is not at parity with any other drugs. D. It will essentially sell itself if it is granted exclusive preferred status. 28. According to your manual, what is a common complaint that physicians have about traditional sampling methods? A. That drug sample supply is too unpredictable B. That patients are less likely to take free samples because they think they are lower quality C. That patients do not like seeing drug representatives in their offices D. That they receive too many drug samples
  • 7. 29. Which of the following would help you build trust with a physician? A. Asking if he or she is having any problems with the managed care coverage of your products B. Repeating a question you already asked C. Surprising the office staff with a new poster in the break room D. None of these would help you build trust with a physician 30. As of November 2013, which of these countries has legalized DTC advertising of prescription drugs? A. Canada B. Japan C. Spain D. None of these 31. Which phase of clinical trial is also known as the pivotal phase? A. Phase I B. Phase III C. Phase IV D. Phase IX 32. During which phase of clinical trials is also known as the pivotal phase? A. Preclinical B. Phase I C. Phase II D. Phase III 33. What is one of the biggest time wasters for a pharmaceutical sales rep? A. Winterers B. Pharmacists C. Receptionists
  • 8. D. Physicians 34. What is the percentage fee that the dispenser pays the wholesaler for distribution? A. Margin fee B. Recharge C. Standard fee D. Upcharge 35. Which of the following is an example of noncompliance? A. A patient forgetting to take a drug at a specified time of day B. A patient taking a drug, but only because it has been court- mandated C. A pharmacist dispensing a generic equivalent of a drug instead of the brand name D. A physician refusing to prescribe a drug because he or she does not trust the clinical studies on it 36. What is one way in which pharmaceutical selling is different from selling in most other industries? A. In pharmaceutical sales, the decision-makers consumers, and payers are usually the same entity B. Pharmaceutical selling takes less time because doctors are so busy. C. Representatives do NOT sell to the user of the product. D. Representatives DO sell to the end user of the product 37. Drugs can be used----- days beyond their expiration date. A. 2-7 days, depending on the most current monograph. B. 2-90 days, depending on the state laws C. 7-90 days, depending on the type of drug and its therapeutic class. D. None of these 38. What issue has MOST encouraged consumers’ desire to see more OTC medications?
  • 9. A. A weaker patients ‘right movement B. Lack of insurance coverage C. Less reliance on the internet D. Proliferation of herbal remedies 39. Which phase of trials largely determines the clinical dose? A. Preclinical trials B. Phase II trials C. Phase III trials D. Phase IV trials 40. What must be contained in the Description section of a pharmaceutical package insert? A. Adverse effects B. Mechanism of action C. Pharmacokinetics D. The proprietary name and the established name 41. Customers purchase products from people they like, trust, and respect. This is called the---------- A. Closing of the sale B. First time advantage C. Likeability factor D. Power of knowledge 42. According to your manual, how has the U.S. healthcare marketplace changed in the last few decades? A. Fewer and fewer prescription drugs have been made available as OTCs. B. Managed care has been increasingly replaced by more patient- centered approaches. C. The aging Baby Boomer generation has begun demanding more personalized attention. D. There has been decreased emphasis on preventive health. 43. How does pharmaceutical marketing help narrow the
  • 10. treatment gap? A. It encourages patients to take more active roles in their healthcare. B. It makes doctors more skeptical of the pharmaceutical industry. C. It makes patients more skeptical of their doctors’ opinions. D. All of these 44. The FDA requirements for nutraceuticals and medicinal herbs are just as stringent as for pharmaceuticals. A. True B. False 45. After a trade-name drug’s patent expires, how may generic versions of it be sold? A. Only under the branded generic name B. Only under the generic name C. Only under the original trade name D. Under the original trade name or a generic name 46. What is required for a new pharmaceutical to be considered a viable therapy? A. It causes no serious adverse effects. B. It causes no side effects. C. It has an active placebo. D. It is more effective and/or causes fewer serious adverse effects than other drugs on the market. 47. A generic version is likely to have some inactive ingredients that are different from those of the original drug. A. True B. False 48. Where are most drugs metabolized? A. Interstitial spaces B. Liver C. Stomach D. The bloodstream
  • 11. 49. What is essential to the ethical requirement that subjects be selected fairly? A. Selection criteria should be well-supported by documented evidence. B. Studies should make every attempt to conduct research on subjects who are underprivileged and in need of medical attention C. Subject should be selected based on scientific objectives. D. All of these 50. Which of the following is NOT typically included in the indications and usage section of the package insert information? A. Diseases or conditions that the drug is approved to treat B. The drug’s active metabolites C. The drug’s recommended usual dosage D. The drug’s usual dosage range